| Korea | Russia | Malaysia
Indonesia | All Others

eg.stem cell, stem cell treatment
Stem cell treatment | Parkinson's Disease | Multiple Sclerosis | ALS | Brain Injury | Spinal Cord Injury | Cerebaral Palsy | Batten Disease | Stroke
MSA | Muscular Dystrophy | Epilepsy | Optic neuritis | Encephalomyelitis | SMA | Huntingdon's disease | Friedrich ataxia | Diabetes
HOME > News > Article Content

Sports Brain Trauma May Cause Disease Mimicking ALS


http://www.sciencedaily.com/releases/2010/08/100817134304.htm

ScienceDaily (Aug. 17, 2010)

New research by the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) and the Department of Veterans Affairs (VA) provides the first pathological evidence that repetitive head trauma experienced in collision sports is associated with motor neuron disease, a neurological condition that affects voluntary muscle movements. The most common form of motor neuron disease is amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.


The findings will be published in the September issue of the Journal of Neuropathology and Experimental Neurology.

The discovery was made by Ann McKee, MD, and colleagues at the CSTE. McKee, a CSTE Co-Director, is an associate professor of neurology and pathology at BUSM, as well as Director of Neuropathology for the Department of Veterans Affairs at the Bedford VA Medical Center, where this research was conducted.

McKee and the CSTE researchers made this groundbreaking pathological discovery while examining the brains and spinal cords of 12 athletes donated by family members to the CSTE Brain Bank at the Bedford VA Medical Center. Three of these 12 athletes, including former professional football players Wally Hilgenberg and Eric Scoggins, as well as an unidentified former military veteran and professional boxer, developed motor neuron disease late in their lives. The former football players were diagnosed clinically with ALS, which is a progressive neurodegenerative disease that attacks motor nerve cells in the brain and spinal cord, resulting in muscle weakness and atrophy. ALS affects fewer than two in 100,000 patients annually, and 30,000 Americans currently live with the disease. The majority of ALS cases (90-95 percent) are considered "sporadic," meaning of unknown cause, although it has long been suspected to involve a complex interaction between multiple genetic and environmental risk factors.

In this study, funded in part by an unrestricted gift from the National Football League (NFL) to the CSTE, McKee found that when they died, all 12 athletes showed neuropathological evidence of chronic traumatic encephalopathy (CTE), a progressive degenerative brain disease characterized by deposits of an abnormal form of tau protein and believed to be caused by repetitive head trauma. In the three athletes with motor neuron disease, abnormal tau protein deposits were not only found throughout the brain, but also in the spinal cord.

CSTE researchers also discovered that 10 of 12 CTE victims had a second abnormal protein, TDP-43, in their brains. Of those 10, only three had TDP-43 in the brain and the spinal cord, and those were the three athletes diagnosed with motor neuron disease. TDP-43 is also found in individuals with sporadic ALS although in the athletes with repetitive brain trauma, the TDP-43 pathology was more severe than found in sporadic ALS and was accompanied by extensive tau pathology. The brains and spinal cords of normal individuals show no TDP-43 or tau deposition.

These new findings suggest that the motor neuron disease that affected the three athletes is similar to, but distinct from sporadic ALS and represents a disease never described previously in the medical literature. This new disease, referred to as chronic traumatic encephalomyopathy (CTEM) by McKee and colleagues is likely caused by the repetitive head trauma experienced by athletes in contact sports.

The association between head trauma and ALS is supported by the medical literature, in which the risk of ALS has been reported to be higher among contact sport athletes and veterans. A study of professional soccer players in Italy found that the incidence rate of ALS was 6.5 times higher than in the general population. An increased incidence of ALS has also been reported in American football players, including three players from the 1964 San Francisco 49ers who died from ALS. Based on the number of retired NFL players with ALS, it is estimated that the risk is at least 8 times higher than in the adult male population. Among Veterans with a history of head injuries, their risk of ALS was 2.3 times higher than normal, and Gulf War Veterans have a twofold increased risk. In fact, since 2008, the US Department of Veterans Affairs has considered ALS as a presumptively compensable illness for all veterans. The discovery of this new ALS-like disease by the BU CSTE investigators suggests that one possible reason for the increased risk of clinically diagnosed ALS in veterans and in contact sport athletes may be the exposure to repetitive head trauma, including concussions, subconcussive blows and blast injuries.

These findings raise the question of whether head injuries may have contributed to Lou Gehrig's motor neuron disease, and whether he also suffered from CTEM. Gehrig, nicknamed the "Iron Horse," played football at Columbia University before becoming a legendary member of the New York Yankees and playing in 2,036 consecutive games, a record that stood for more than 60 years. Gehrig suffered at least five documented concussions and was reported to have been knocked unconscious for five minutes after taking a pitch to the head while not wearing a helmet. He played the next day.
"When we read reports about cases of the disease being linked to specific activities or experiences, such as the increased risk associated with military service, or this one regarding professional athletes, we are reminded of just how complex of a disorder ALS is. We're hopeful that this new work may shed light on potentially exciting new possibilities for biomarker and therapy development," said Steve Perrin, PhD, CEO and Chief Scientific Officer of the ALS Therapy Development Institute.

Responding to these new findings, Hunt Batjer, MD and Richard Ellenbogen, MD, the co-chairmen of the NFL's new Head, Neck and Spine Committee, stated, "We are pleased that the NFL has provided the support necessary for this research and look forward to continued discussion of the findings within our medical committee and with other researchers to better understand their clinical implications."

McKee now has analyzed the brains of more than 35 athletes and found evidence of CTE in 12 of 13 former NFL players. These brains were acquired primarily through the efforts of CSTE co-director Chris Nowinski who is also president of the non-profit Sports Legacy Institute. The CSTE maintains a registry of more than 350 living athletes who have agreed to donate their brain and spinal cord following death and to undergo telephone-based interviews and assessments during life. Robert Stern, PhD, CSTE co-director and an associate professor of neurology at BUSM, oversees the CSTE registry as well as a study about to begin of retired NFL players who undergo extensive neurological, cognitive, psychiatric, cerebrospinal fluid and neuroimaging studies. Robert Cantu, MD, a clinical professor of neurosurgery at BUSM and co-director of the CSTE, was recently appointed senior advisor to the NFL Head, Neck and Spine Committee.



Related Information:

  • The Washington Post report regarding our center and specialized stem cell treatment   
  • Stem cell therapy, a promising novel endeavor for neurological disorders   
  • Major ALS breakthrough-common cause of all forms of ALS discovered   
  • Imaging Study Shows Slower Growth In Autistic Brains Extending Into Adolescence   
  • 'Pushing Limits' - New Drug Strategies For Alzheimer's, Multiple Sclerosis   
  • Study Suggests Varying Practice Sessions May Benefit People With Motor Disorders   
  • New Drug Strategies for Alzheimer's and Multiple Sclerosis   
  • Antiviral Drugs May Slow Alzheimer's Progression   
  • Precision With Stem Cells a Step Forward for Treating Multiple Sclerosis, Other Diseases   
  • Minority Children Less Likely to Receive CT Scans Following Head Trauma   
  • Reassurance for Dementia Sufferers On Impact of Common Drugs   
  • Understanding the Beginnings of Embryonic Stem Cells Helps Predict the Future   
  • By Reprogramming Skin Cells Into Brain Cells, Scientists Gain New Insights Into Mental Disorders   
  • Family History May Have More Important Role Than Previously Thought in Development of Alzheimer Disease   
  • Evidence Points to Potential Roles for Cognitive Rehabilitation Therapy in Treating Traumatic Brain Injury,   
  • New Drug Target for Alzheimer's, Stroke Discovered   
  • New Drug Target for Alzheimer's, Stroke Discovered   
  • A Safe Vaccination for Alzheimer's Disease?   
  • Think You're in Poor Health? It Could Increase Your Odds of Dementia   
  • Models of Autism Show That Gene Copy Number Controls Brain Structure and Behavior   
  • Patient-Specific Stem Cells: Major Step Toward Cell-Based Therapies for Life-Threatening Diseases   
  • One Quarter of Seniors Over 70 Have Had Silent Strokes   
  • Remitting Multiple Sclerosis: Natalizumab Reduces Relapses and Disability   
  • Seeds of Destruction in Parkinson's Disease: Spread of Diseased Proteins Kills Neurons   
  • Even High-But-Normal Blood Pressure Elevates Stroke Risk   
  • Commonly Used Supplement May Improve Recovery from Spinal Cord Injuries   
  • Key to Survival of Brain Cells Discovered   
  • Correcting Sickle Cell Disease With Stem Cells   
  • New Stem Cell Activity Identified in Human Brain   
  • New Stem Cell Activity Identified in Human Brain   
  • Treatment
    The Parkinson's Clinical Center
    Doctor Blogs
    Treatment Data
    Contact Us

  • What are stem cells and how do they work to treat various diseases?   
  • How do stem cells know where to go and what to do?   
  • What kinds of stem cells does your medical center use and are they safe?   
  • Where do the stem cells come from?   
  • Is stem cell treatment safe? Is it really effective?   
  • How do I know if I am a good candidate for stem cell therapy?   
  • How long should I expect to stay in Beijing for the treatment?   
  • Can you use adult stem cells from my own bone marrow?   
  • What methods do you use to transplant stem cells into the patient's body?   
  • What should I expect to experience during the stem cell treatment?   
  • Do the doctors use anesthesia during the operation?   
  • What other drugs does the doctor combine with the stem cells for therapy?   
  • How long after surgery will it be before I can bathe or shower?   
  • For Batten disease treatment, what type of stem cells are used?   
  • About the neural growth factors that your medical center use   
  • If your hospitals have an age restriction on patients?   
  • What medications do you use on Batten disease patients?   
  • Is it possible for you to manufacture the TPP1 enzyme and deliver it?   
  • When I send my records to your hospital, does a doctor read them?   
  • Is general anesthesia used?   
  • Is other therapy done in addition to stem cell infusion?   
  • What types of rehabilitation training is done?   
  • What will my treatment schedule be like?   
  • Does the doctor have to penetrate the spinal canal to infuse the stem cells   
  • If I have to have surgery, how long will it take for the wound to heal?   
  • Will I lose very much blood?   
  • If there is surgery, can I fly back home before the wound has healed?   
  • Does your medical center also offer conventional treatment?   
  • What is the most effective way to contact us?   
  • Are stem cells pre-tested for HIV and Hepatitis? What else do you test?   
  • Send Inquiry Contact Us Sitemap Help

    Link:Like Cell Research Center | stemcellshezhong.com
    Copyright © 2011 unistemcells.com All rights reserved.